(Q40614720)

22 September 2017

title

Experimental study on the possibility of treatment of some hemorrhagic fevers (English)

1 reference

22 September 2017

Ignatyev G

1

1 reference

22 September 2017

Steinkasserer A

2

1 reference

22 September 2017

Streltsova M

3

1 reference

22 September 2017

Atrasheuskaya A

4

1 reference

22 September 2017

Agafonov A

5

1 reference

22 September 2017

Lubitz W

6

1 reference

22 September 2017

publication date

1 September 2000

1 reference

22 September 2017

published in

Journal of Biotechnology

1 reference

22 September 2017

volume

83

1 reference

22 September 2017

issue

1-2

1 reference

22 September 2017

page(s)

67-76

1 reference

Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Arenaviral haemorrhagic fevers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Early diagnosis of Lassa fever by reverse transcription-PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

A novel endothelial-specific membrane protein is a marker of cell-cell contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1656%2800%2900300-X

7 January 2021

10.1016/S0168-1656(00)00300-X

Identifiers

DOI

1 reference

22 September 2017

1 reference